These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1786369)

  • 1. [Effects of antibodies to dopamine-beta-monooxygenase on the level of catecholamines in the brain].
    Pogosian AS; Boiadzhian AS; Karagezian KG; Aĭvazian VA; Movsesian AV
    Biull Eksp Biol Med; 1991 Aug; 112(8):133-4. PubMed ID: 1786369
    [No Abstract]   [Full Text] [Related]  

  • 2. The catecholaminergic system of the quail brain: immunocytochemical studies of dopamine beta-hydroxylase and tyrosine hydroxylase.
    Bailhache T; Balthazart J
    J Comp Neurol; 1993 Mar; 329(2):230-56. PubMed ID: 8095939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebral catecholamines in experimental excessive emotional stress].
    Belova TI; Kvetnanskiĭ R
    Usp Fiziol Nauk; 1981; 12(2):67-90. PubMed ID: 6115522
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune lesions of central noradrenergic nerves in the rat produced by antibodies to dopamine-beta-hydroxylase.
    Blessing WW; Costa M; Geffen LB; Rush RA
    Clin Exp Neurol; 1978; 15():307-8. PubMed ID: 756021
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by endogenous 6-hydroxydopamine.
    Stein L; Wise CD
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():298-314. PubMed ID: 5071537
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of some dithiocarbamic acids on dopamine-beta-hydroxylase and catecholamines level in rat's brain.
    Przewlocka B; Sarnek J; Szmigielski A; Niewiadomska A
    Pol J Pharmacol Pharm; 1975; 27(5):555-9. PubMed ID: 1187458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biosynthesis of catecholamines: new concepts].
    Laduron P
    Actual Pharmacol (Paris); 1974; 27():45-67. PubMed ID: 4157158
    [No Abstract]   [Full Text] [Related]  

  • 9. [Schizophrenia and neurotransmitters].
    Nagatsu T; Fujita K; Kawai K; Shinpo K; Shinzato M
    Nihon Rinsho; 1984 Apr; 42(4):891-901. PubMed ID: 6384571
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights into the reptilian catecholaminergic systems as revealed by antibodies against the neurotransmitters and their synthetic enzymes.
    Smeets WJ; Steinbusch HW
    J Chem Neuroanat; 1990; 3(1):25-43. PubMed ID: 1969276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbamazepine decreases catecholamine turnover in the rat brain.
    Waldmeier PC; Baumann PA; Fehr B; De Herdt P; Maitre L
    J Pharmacol Exp Ther; 1984 Oct; 231(1):166-72. PubMed ID: 6491972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-dopamine beta-hydroxylase immunotoxin-induced sympathectomy in adult rats.
    Picklo MJ; Wiley RG; Lonce S; Lappi DA; Robertson D
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1003-10. PubMed ID: 7473126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat.
    Browning RA; Wade DR; Marcinczyk M; Long GL; Jobe PC
    J Pharmacol Exp Ther; 1989 Apr; 249(1):229-35. PubMed ID: 2709332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of metallothionein-I+II levels in specific brain areas and liver in the rat: role of catecholamines.
    Gasull T; Giralt M; Garcia A; Hidalgo J
    Glia; 1994 Oct; 12(2):135-43. PubMed ID: 7868187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The action of 2-amino-4-(isothioureyl methyl)-thiazol dihydrochloride (Agr 307) on the catecholamines of the central nervous system in the rat. Possible inhibition of dopamine beta-hydroxylase].
    Brunaud M; Vallée E; Laborit H
    Agressologie; 1971; 12(2):113-8. PubMed ID: 5123844
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain.
    Vetulani J; Reichenberg K; wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1973; 25(6):559-72. PubMed ID: 4792476
    [No Abstract]   [Full Text] [Related]  

  • 19. Some central adrenergic mechanisms connected with the animals ability to form instrumental conditioned reflexes.
    Krause M; Gwòzdz B
    Acta Physiol Pol; 1973; 24(1):93-5. PubMed ID: 4716351
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase.
    Vetulani J
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):501-6. PubMed ID: 4730817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.